Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **splicing factor 4 pseudogene** (ENSG00000250405) is a human genomic region annotated as a pseudogene, i.e. a segment similar in sequence to the gene encoding splicing factor 4 (SF4) but does not encode a functional protein[1][5]. Pseudogenes typically arise from gene duplication or retrotransposition events but have lost protein-coding function due to mutations and/or absence of proper regulatory elements. The SF4 pseudogene shares sequence homology with the functional splicing factor 4 gene, a member of the SR protein family that regulates pre-mRNA splicing, but is not expressed nor translated into a functional product. As such, it does not participate in spliceosome function, does not contribute to splicing regulation, and is not considered a therapeutic target nor a disease gene. It is commonly referenced for genomic annotation but bears no known biological or clinical relevance. \n\n**Additional Context:**\n- Pseudogenes like this one are widespread in the human genome and may occasionally regulate expression of their parent genes via non-coding RNA mechanisms, but no evidence supports such a regulatory role for the splicing factor 4 pseudogene[1][5].\n- The functional analog, **splicing factor 4 (SF4 or SRSF4)**, is a member of the serine/arginine-rich family of splicing factors, involved in pre-mRNA splicing and implicated in various diseases[3][4], but ENSG00000250405 itself does not encode this protein.\n- The presence of \"pseudogene\" in the name and genome annotation reliably indicates it is not a therapeutic target.\n\n**Summary:** \nENSG00000250405 (splicing factor 4 pseudogene, LOC402229) is a non-functional, non-coding pseudogene and not a valid therapeutic target. Any references to drug interactions, functional mechanisms, or clinical utility should refer to the actual SF4 protein or gene (SRSF4), not this pseudogene[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Splicing factor 4 pseudogene (SF4 pseudogene).